Measurement of B-type natriuretic peptide by two assays utilizing antibodies with different epitope specificity

Clinical Biochemistry

Volumn 44, Issue 2-3, 2011, Pages 257-259

  Tamm, Natalia N ^a   Semenov, Alexander G ^a   Seferian, Karina R ^a   Bereznikova, Anastasia V ^b   Murakami, MaryAnn M ^c   Apple, Fred S ^c   Koshkina, Ekaterina V ^d   Krasnoselsky, Mihail I ^e   Katrukha, Alexey G ^a  

^a HyTest Ltd   (Finland)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d 67 City Hospital   (Russian Federation)

^e A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

Author keywords

BNP; Heart failure; Proteolytic degradation; Sandwich type immunoassays

Indexed keywords

ANTIBODY; BRAIN NATRIURETIC PEPTIDE; EPITOPE; PEPTIDE FRAGMENT;

AGED; ARTICLE; CALIBRATION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HEART FAILURE; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; BLOOD; IMMUNOLOGY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES; EPITOPES; ESCHERICHIA COLI; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SENSITIVITY AND SPECIFICITY;

EID: 79151473054     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.09.030     Document Type: Article

References (8)

1. Mueller T., Gegenhuber A., Poelz W., Haltmayer M. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem 2004, 50:1104-1106.
2. Wu A.H., Packer M., Smith A., Bijou R., Fink D., Mair J., et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004, 50:867-873.
3. Del Ry S., Clerico A., Giannessi D., Andreassi M.G., Caprioli R., Iascone M.R., et al. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method. Scand J Clin Lab Invest 2000, 60:81-90.
4. Fischer Y., Filzmaier K., Stiegler H., Graf J., Fuhs S., Franke A., et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001, 47:591-594.
5. Apple F.S., Panteghini M., Ravkilde J., Mair J., Wu A.H., Tate J., et al. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005, 51:486-493.
6. Liang F., O'Rear J., Schellenberger U., Tai L., Lasecki M., Schreiner G.F., et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 2007, 49:1071-1078.
7. Niederkofler E.E., Kiernan U.A., O'Rear J., Menon S., Saghir S., Protter A.A., et al. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circ Heart Fail 2008, 1:258-264.
8. Tamm N.N., Seferian K.R., Semenov A.G., Mukharyamova K.S., Koshkina E.V., Krasnoselsky M.I., et al. Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood. Clin Chem 2008, 54:1511-1518.